Explore the latest in health care reform, including innovations in health care delivery and payment models, the politics of reform, and more.
This cross-sectional study evaluates the association of the implementation of the US Patient Protection and Affordable Care Act with out-of-pocket spending, premiums, and catastrophic health expenditures among adults with traumatic injuries.
This cohort study measures changes in tax-exempt hospital spending with community benefit and changes in uncompensated care after Medicaid expansion.
This cross-sectional study examines the association between Medicaid expansion following the Patient Protection and Affordable Care Act (ACA) and changes in insurance status, cancer stage at diagnosis, and timely treatment among patients with incident breast, colon, and non–small cell lung cancer.
This cohort study assesses temporal trends in 30-day readmission and mortality rates among black and nonblack patients discharged after hospitalization for acute myocardial infarction at hospitals defined as low-performing and high-performing per their Hospital Readmissions Reduction Program penalty status.
This survey study assesses the association of Medicaid expansion in Michigan with enrollees’ employment or student status.
This Viewpoint emphasizes the value of randomized evaluation of policies and programs designed to improve health behaviors, health outcomes, and health care delivery, and articulates preconditions that appear to be essential for the practice to become more of a standard in policy implementation.
This Viewpoint proposes ways to implement the Centers for Medicare & Medicaid Services’ requirement that Medicare Part D plan sponsors implement electronic health record–integrated real-time drug benefit tools to help physicians and patients have point-of-care medication cost information, calling for use of standardized price information and demonstration projects to ensure the rule does not impose unnecessary administrative and technological burden on clinicians.
This cohort study evaluates the associations of patient, prescriber, and geographic region with differences in time to first prescription of biologic disease-modifying antirheumatic drug among older adults with rheumatoid arthritis and identical health insurance coverage in Ontario, Canada.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: